Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder

What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review

(2023) Inmaculada Baeza et al.   PEDIATRIC DRUGS

Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs

(2022) Stefan Leucht et al.   PHARMACOPSYCHIATRY

Trends in the use of long-acting injectable antipsychotics in children and adolescents in France between 2014 and 2018

(2022) Xavier Benarous et al.   SCHIZOPHRENIA RESEARCH

The use of first-generation long-acting injectable antipsychotics in children and adolescents—A retrospective audit from India

(2021) Preeti Jacob et al.   Asian Journal of Psychiatry

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia

(2020) John M. Kane et al.   JAMA Psychiatry

Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study

(2018) Adriana Fortea et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Long-Acting Injectable Antipsychotics in Children and Adolescents

(2017) Sarah Lytle et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not

(2017) M. Aas et al.   PSYCHOLOGICAL MEDICINE

The link between schizophrenia and substance use disorder: A unifying hypothesis

(2017) Jibran Y. Khokhar et al.   SCHIZOPHRENIA RESEARCH